The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global R&D in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by GHTC.
Learn more
GHTC delivered a statement at the 74th World Health Assembly calling on the World Health Organization and member states to strengthen the capacity of national and regional regulatory functions and systems. The statement, issued through the Global Health Council, also urges member states to support a resolution to strengthen local production of medicines and health technologies, as well as ensure better regional collaboration for regulatory functions.
Learn more
GHTC joined a civil society statement at the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to strengthen vaccine-related research and innovation with the most vulnerable populations in mind and increase investment in R&D for new health technologies to fight antimicrobial resistance (AMR). The statement, issued through the Global Health Council, urges WHO and member states to support research on the full spectrum of product needs, including vaccine administration, storage, and delivery innovations, as well as new antimicrobials, diagnostics, and vaccines to address the threat of AMR.
Learn more
GHTC joined a civil society statement to the 74th World Health Assembly outlining the transformative progress achieved in developing and facilitating access to malaria prevention and treatment tools through the World Health Organization (WHO) Global Technical Strategy for Malaria 2016–2030. The statement, issued through the Medicines for Malaria Venture and PATH, urges WHO and member states to address the fragility of health systems and increase investments to drive innovation and uptake of tools, including through more efficient processes for prequalification of products and revision of guidelines.
Learn more
GHTC joined the Global Health Council in its statement to the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to prioritize R&D capacity strengthening within global frameworks to strengthen pandemic preparedness. The statement specifically urges WHO and member states to prioritize regional research and manufacturing capacity, increase International Health Regulation compliance, and strengthen medical and pharmaceutical supply chains in advance of health emergencies.
Learn more
GHTC statement on the Rome Declaration from the G20 Global Health Summit.
Learn more
GHTC statement in advance of the World Health Organization (WHO) inaugural forum with non-state actors.
Learn more
As the G20 Health Working Group meets next this Thursday and Friday, GHTC urges them to prioritize several actions to bolster R&D to defeat COVID-19, mitigate its impacts, and combat other long-standing and emerging threats.
Learn more
The U.S. Congress and Biden-Harris administration have a clear opportunity to supercharge global R&D in the wake of a pandemic that has revealed both the sector’s chronic neglect and amazing potential, according to a detailed agency-by-agency action plan released today by GHTC.
Learn more
Health Policy Watch covered a webinar co-hosted by GHTC examining how to shift the paradigm to increase gender equity in health R&D.
View
Health Policy Watch featured a commentary from GHTC Director Jamie Bay Nishi outlining six steps for the US government to pivot from the pandemic to a golden era of global health R&D.
View
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was featured in a news story on LaboratoryEquipment.com.
View
GHTC's policy report Meeting the moment, fueling the future: Policy recommendations for a new era of leadership in global health R&D was features on the website NewsMedical.net.
View
GHTC delivered a statement at the 74th World Health Assembly calling on the World Health Organization and member states to strengthen the capacity of national and regional regulatory functions and systems. The statement, issued through the Global Health Council, also urges member states to support a resolution to strengthen local production of medicines and health technologies, as well as ensure better regional collaboration for regulatory functions.
Learn more
GHTC joined a civil society statement at the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to strengthen vaccine-related research and innovation with the most vulnerable populations in mind and increase investment in R&D for new health technologies to fight antimicrobial resistance (AMR). The statement, issued through the Global Health Council, urges WHO and member states to support research on the full spectrum of product needs, including vaccine administration, storage, and delivery innovations, as well as new antimicrobials, diagnostics, and vaccines to address the threat of AMR.
Learn more
GHTC joined a civil society statement to the 74th World Health Assembly outlining the transformative progress achieved in developing and facilitating access to malaria prevention and treatment tools through the World Health Organization (WHO) Global Technical Strategy for Malaria 2016–2030. The statement, issued through the Medicines for Malaria Venture and PATH, urges WHO and member states to address the fragility of health systems and increase investments to drive innovation and uptake of tools, including through more efficient processes for prequalification of products and revision of guidelines.
Learn more
GHTC joined the Global Health Council in its statement to the 74th World Health Assembly calling on the World Health Organization (WHO) and member states to prioritize R&D capacity strengthening within global frameworks to strengthen pandemic preparedness. The statement specifically urges WHO and member states to prioritize regional research and manufacturing capacity, increase International Health Regulation compliance, and strengthen medical and pharmaceutical supply chains in advance of health emergencies.
Learn more
Center for Global Development, Transparency International
Virtual
View
GHTC
Virtual
View
Consortium of Universities for Global Health
Virtual
View
Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
(202) 540-4414
mchmiola@ghtcoalition.org